Jose L. Cataneo, MD, on Limited English-Language Proficiency Being a Risk Factor

News
Video

Research suggested that limited English-language proficiency is a risk factor for getting potentially lifesaving screening mammograms less often.

A study presented at the American College of Surgeons Clinical Congress 2020 suggested that limited English-language proficiency (LEP) is a risk factor for getting potentially lifesaving screening mammograms less often.

Of note, LEP was defined as speaking only or mostly a language besides English.

“Spanish-only speakers appear to have a 27% less likelihood of having a screening mammogram than English speakers,” lead study investigator Jose L. Cataneo, MD, a general surgery resident at the University of Illinois at Chicago/Metropolitan Group Hospitals, said in a press release.

Using the National Health Interview Survey from 2015, an annual survey of US civilian, noninstitutionalized residents, researchers evaluated women between the age of 40 and 75 years old, the age range usually recommended for screening mammography, who answered the survey with which language they primarily speak.

Of 9653 women included in the study, 1040 were found to have LEP; 712 of these women spoke only Spanish. Among 936 LEP group members who provided mammogram information, the overall rate of screening mammograms was 12% less than for proficient English speakers (78% vs 90%).

Given that US mammography guidelines vary by age, researchers examined participants in different age groups, including those aged 40 to 50, those aged 45 to 75, and those aged 50 to 75. Across all 3 groups, those with limited English proficiency had less frequency of getting a screening mammogram. Following propensity score matching, speaking only Spanish still predicted a significantly lower probability of getting a screening mammogram, with an odds ratio of 0.73.

In an interview with CancerNetwork®, Cataneo discussed the study findings and what the implications are for this patient population.

This segment comes from the CancerNetwork® portion of the MJH Life Sciences Medical World News, airing daily on all MJH Life Sciences channels.

Reference:

Female Spanish-only speakers get screening mammograms less often than other women [news release]. Chicago. Published October 3, 2020. Accessed October 7, 2020.

Recent Videos
According to John Henson, MD, “What we need are better treatments to control the [brain] tumor once it’s detected.”
First-degree relatives of patients who passed away from pancreatic cancer should be genetically tested to identify their risk for the disease.
Destigmatizing cancer care for incarcerated patients may help ensure that they feel supported both in their treatment and their humanity.
A lower percentage of patients who were released within 1 year of incarceration received guideline-concurrent care vs incarcerated patients.
A collaboration between the Connecticut Departments of Health and Corrections and the COPPER Center aimed to improve outcomes among incarcerated patients.
Computational models help researchers anticipate how ADCs may behave in later lines of development, while they are still in the early stages.
ADC payloads with high levels of potency can sometimes lead to higher levels of toxicity, which can eliminate the therapeutic window for patients with cancer.
According to Greg Thurber, PhD, target-mediated uptake is the biggest driver of efficacy for antibody-drug conjugates as a cancer treatment.
Co-hosts Kristie L. Kahl and Andrew Svonavec highlight what to expect at the 43rd Annual Chemotherapy Foundation Symposium, such as new chemotherapeutics and targeted therapies.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Related Content